Entry Detail



General Information

Database ID:exR0275628
RNA Name:hsa-miR-450b-5p
RNA Type:miRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):134540231End Site(bp):134540252
External Links:hsa-miR-450b-5p



Disease Information

Disease Name:Advanced Adenoma
Disease Category:Cancers
MeSH ID:D000236
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas



Expression Detail

GEO ID:GSE25609
Description:Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening
Experimental Design:Cancer vs Control
Case Disease Type:Advanced Adenoma
Case Disease SubType:NA
Case Sample:Advanced Adenoma Post surgery
Control Sample:Control
Number of Case:20
Number of Control:20
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CPSF2
chr14
92121969
92172145
+
DUSP14
chr17
37489891
37513501
+
MEF2A
chr15
99565417
99716466
+
VCP
chr9
35056064
35072627
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0000418
chr12
69983264
69985939
+
hsa_circ_0001492
chr5
65284462
65290692
+
hsa_circ_0000284
chr11
33307958
33309057
+
hsa_circ_0000494
chr13
76134888
76143643
+
hsa_circ_0000943
chr19
47421744
47440665
+
hsa_circ_0000398
chr12
46633461
46637097
-
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
A1BG-AS1
chr19
58347718
58355455
+
AC005034.3
chr2
75697583
75697996
+
AC010327.5
chr19
55216660
55221616
+
AC105339.2
chr15
82752884
82757208
+
AL049795.2
chr1
32170733
32176568
+
AL137782.1
chr13
75549773
75807120
+
FGD5-AS1
chr3
14920347
14948424
-
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG1
chr11
62851984
62855953
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE25609
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL8179
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:826
Sample treatment protocol:Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components.
RNA Extract protocol:NA
RNA library preparation protocol:Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).



Reference

PMID:23267864
Title:Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study
Author:Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M
Journal:Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3.
Description:We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.